Goal 13 of the UN SDG calls for Climate Action. Relative to output, drug manufacturing and supply chains contribute considerably to CO2 emissions. Small molecule drug production remains an ecologic burden due to their high E factor (ratio of kg waste/kg product). Biopharma manuf. increasingly depends on disposables. Delivery devices are mostly single-use plastics.